• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Combivent (ipratropium bromide and albuterol sulfate) Inhalation Aerosol

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009

 

Summary View

 

WARNINGS

Cardiovascular Effect
  • There is some evidence from post-marketing data and published literature of rare occurrences of myocardial ischemia associated with albuterol.